APRIL SINK: Open Payments
NPI 1659761302 · THOMASVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 17 payments from 13 companies in 2025. Trend: 2023 $237 · 2024 $120 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Tempus AI, Inc | 3 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Aveo Pharmaceuticals, Inc. | 1 | $34 |
| Adaptive Biotechnologies Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Genmab U.S., Inc. | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $22 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $21 |
Products named: XT CDX, OPDIVO, FOTIVDA, clonoSEQ, JEMPERLI, Tivdak, JAKAFI, Trodelvy.
Industry payments across NC — which companies pay providers there.
